Video shows large orange flames and smoke rising into the night sky, as Qatar Interior Ministry says at least 54 people injured and 18 missing after explosion at factory in Ras Laffan. Hungary PM ...
MIAMISBURG, Ohio (WDTN) – Beginning this week, Benner Road will be reduced to a two-way one-lane road. A culvert on the road was found to be in a critical state of deterioration, requiring ...
Federal officials are laying more groundwork to begin construction on President Donald Trump’s planned 250-foot-tall triumphal arch, sharing additional documents that detail the project’s scope and an ...
UVM students help clear leaves from a culvert as part of the Culvert Crawlers program. Photo courtesy Charis Boke A tube of corrugated metal running under a road might not look like much. But when the ...
The National Park Service is calling on the public to provide their input on the potential effects of a 250-foot arch being proposed by President Donald Trump. The Triumphal Arch would be built at ...
WASHINGTON (7News) — The National Park Service (NPS) is asking the public to weigh in on a report examining the potential effects of a proposed Triumphal Arch within the George Washington Memorial ...
The Federal Aviation Administration advised that if the Trump administration adds red obstruction lights to the arch design, it is likely to pose no risk to local aviation. By Karoun Demirjian The ...
Donald Trump‘s proposed arch, which has been surrounded by controversy for months, will feature an observation deck. However, it remains unclear how the monument will be easily accessible to visitors.
The mammoth triumphal arch President Trump wants to build would sit under one of the most complex sections of the national airspace — directly in the paths of flights in and out of Ronald Reagan ...
President Donald Trump’s plan to build a huge arch near Arlington National Cemetery was up for review Thursday and was met by protests. The National Capital Planning Commission will evaluate the plan ...
This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.